Motohiro Kato, MD, PhD^1,2, Takuya Yamashita, MD, PhD³, Ritsuro Suzuki, MD, PhD⁴, Kimikazu Matsumoto, MD, PhD^5*, Hisakazu Nishimori^6*, Satoshi Takahashi, MD⁷, Koji Iwato, MD^8*, Chiaki Nakaseko, MD, PhD⁹, Tadakazu Kondo, MD¹⁰, Kazunori Imada^11*, Fumihiko Kimura, MD¹², Tatsuo Ichinohe, MD, Ph.D¹³, Yoshiko Hashii, MD, PhD¹⁴, Koji Kato, MD, PhD¹⁵, Yoshiko Atsuta, MD, Ph.D^16,17*, Shuichi Taniguchi, MD, PhD¹⁸ and Takahiro Fukuda, MD^3*

¹University of Tokyo, Tokyo, Japan
²National Center for Child Health and Development, Tokyo, Japan
³Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
⁴Department of HSCT Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁵Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
⁶Okayama University, Okayama, Japan
⁷Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁸Department of Transfusion, Hiroshima Red Cross Hospital, Hiroshima, Japan
⁹Department of Hematology, Chiba University Hospital, Chiba, Japan
¹⁰Kyoto University Graduate School of Medicine, Kyoto, Japan
¹¹Kokura Kinen Hospital, Fukuoka, Japan
¹²Division of Hematology, National Defense Medical College, Tokorozawa, Japan
¹³Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan
¹⁴Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
¹⁵Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
¹⁶Japanese Data Center for Haematopoietic Cell Transplantation, Nagoya, Japan
¹⁷Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
¹⁸Department of Hematology, Toranomon Hospital, Tokyo, Japan

Matthew S. Davids, MD¹, Haesook T. Kim, PhD^2*, Caitlin L. Costello, MD³, Peter A. McSweeney, MD⁴, Rebecca Liguori^5*, Alexander Lukez^5*, David Avigan, MD⁶, Yi-Bin Chen, MD⁷, Nicole LeBoeuf^8*, Vincent T. Ho, MD⁵, Corey S Cutler, MD, MPH⁹, John Koreth, MBBS, DPhil⁵, Edwin P. Alyea, MD⁵, Joseph H Antin, MD⁵, Jerome Ritz, MD¹⁰, Philippe Armand, MD, PhD¹, Edward D Ball, MD¹¹, Asad Bashey, MD, PhD¹² and Robert J. Soiffer, MD⁵

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
³Moores UCSD Cancer Center, La Jolla, CA
⁴Rocky Mountain Cancer Center, Denver, CO
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Beth Israel Deaconess Medical Center, Boston, MA
⁷Massachusetts General Hospital, Boston, MA
⁸Department of Dermatology, Brigham & Women’s Hospital, Boston, MA
⁹Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁰Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
¹¹Division of Blood and Marrow Transplantation, UCSD, La Jolla, CA
¹²The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA

Anthony Selwyn Stein, MD¹, Max S. Topp, MD², Hagop M Kantarjian, MD³, Nicola Goekbuget, MD⁴, Ralf C Bargou, MD⁵, Mark R Litzow, MD⁶, Alessandro Rambaldi, MD⁷, Josep Ribera, MD, PhD⁸, Alicia Zhang, PhD^9*, Zachary Zimmerman, MD, PhD^9* and Stephen J. Forman, MD¹

¹Gehr Leukemia Center, City of Hope Medical Center, Duarte, CA
²Department of Internal Medicine II, Division of Hematology and Medical Oncology, Wuerzburg University Medical Center, Wuerzburg, Germany
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Medicine II, Goethe University, Frankfurt, Germany
⁵Department of Hematology and Oncology, University Hospital Wurzburg, Wurzburg, Germany
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⁸Department of Hematology, ICO Badalona-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autonoma de Barcelona, Badalona, Spain
⁹Amgen, Inc, Thousand Oaks, CA

Partow Kebriaei, MD¹, Stefan O. Ciurea, MD¹, Mary Helen Huls, BS^2*, Harjeet Singh, PhD³, Simon Olivares, BS^3*, Shihuang Su, BS^4*, Matthew J. Figliola, BS^3*, Pappanaicken Kumar, PhD^4*, Bipulendu Jena, PhD^5*, Marie-Andree Forget, PhD^4*, Sonny Ang, PhD^4*, Rineka Jackson, BS^4*, Tingting Liu, BS^6*, Ian K. McNiece, PhD⁷, Gabriela Rondon, MD¹, Perry Hackett, PhD^8*, Hagop M. Kantarjian, MD⁹, Dean A. Lee, MD, PhD¹⁰, Uday R. Popat, MD¹, Amin Alousi, MD¹¹, Betul Oran, MD¹, Nina Shah, MD¹², Chitra M. Hosing, MD¹, David Marin, MD^1*, Katayoun Rezvani, M.D., PhD¹, Elizabeth J. Shpall, MD¹ and Richard E. Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Pediatrics Research, U.T. M.D Anderson Cancer Center, Houston, TX
³Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Pediatrics-Research, MD Anderson Cancer Center, Houston
⁵Pediatrics-Research, University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸University of Minnesota, St. Paul
⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Pediatric Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX
¹¹UT-MD Anderson Cancer Ctr., Houston, TX
¹²M.D. Anderson Cancer Center, Houston, TX

Christoph Schmid, MD¹, Myriam Labopin, MD^2,3*, Hendrik Veelken, MD, PhD⁴, Nicolaas P.M. Schaap, MD, PhD⁵, Michael Schleuning⁶, Michael Stadler, MD^7*, Juergen Finke, MD⁸, Yves Beguin, MD, PhD^9,10, Matthew Collin, MD, PhD^11,12, Per T. Ljungman, MD, PhD¹³, Gesine Bug, MD^14*, Didier Blaise, MD, PhD¹⁵, Johanna Tischer, MD^16*, Adrian Bloor, FRCPath^17*, Boris Afanasyev, MD PhD^18*, Sebastian Giebel, MD, PhD^19*, Norbert Claude Gorin, Pr, MD, PhD²⁰, Jordi Esteve²¹, Fabio Ciceri, MD^22*, Bipin N. Savani, MD²³, Frederic Baron, MD, PhD^24,25, Audrey Mailhol^26*, Arnon Nagler, MD, MSc²⁷ and Mohamad Mohty, MD, PhD^28,29

¹Ludwig-Maximilians-University of Munich, Germany, Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany
²Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France
³EBMT, Acute Leukemia Working Party, Paris, France
⁴Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
⁵Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
⁶Centre for hematopoietic cell transplantation, German Diagnostic Clinic, Wiesbaden, Germany
⁷Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
⁸Hematology/Oncology, University Medical Center Freiburg, Freiburg, Germany
⁹Division of Hematology, Department of Medicine, University and CHU of Liège, Liège, Belgium
¹⁰Laboratory of Hematology, GIGA-I3, University of Liège, Liège, Belgium
¹¹Haematological Sciences, Institute of Cellular Medicine, Newcastle Upon Tyne, England
¹²Haematological Sciences, Newcastle University, Newcastle, United Kingdom
¹³Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
¹⁴Department of Medicine, Hematology/Oncology, University of Frankfurt, Frankfurt, Germany
¹⁵Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
¹⁶Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany
¹⁷The Christie NHS Foundation Trust, Manchester, United Kingdom
¹⁸Memorial R.M. Gorbacheva Institute of Children Hematology and Transplantation, St. Petersburg Pavlov State Medical University, St. Petersburg, Russia
¹⁹Dept. of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
²⁰Hematology-cell therapy and EBMT, Hopital Saint-Antoine and Universite Pierre et Marie Curie UPMC, Paris, France
²¹Hospital Clinic de Barcelona, Spanish MDS Cooperative Group, Barcelona, Spain
²²Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milano, Italy
²³Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
²⁴University of Liege, Liege, Belgium
²⁵Hematology and GIGA Research, CHU Sart Tilman, Liege, Belgium
²⁶Hôpital Saint Antoine, EBMT Paris Study Office, Paris, France
²⁷Division of Hematology and Bone Marrow Transplantation, Division of Hematology & Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, Israel Transplantation, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, Tel Hashomer, Israel
²⁸Hôpital Saint-Antoine, EBMT Office Paris, Paris, France
²⁹Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France

Andrew M. Brunner, MD^1,2, Shuli Li^2*, Amir T. Fathi, MD¹, Vincent T Ho, MD², Richard M. Stone, MD³, Robert J. Soiffer, MD² and Yi-Bin Chen, MD¹

¹Massachusetts General Hospital, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA